Top compounds associated with response to MAP2K1


Feature Type Standardized
Nominal ANOVA
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.16 2e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 8e-07
mRNA Axitinib CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.15 3e-06
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA PX-12 CTRPv2 pan-cancer AAC -0.12 1e-05
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.13 2e-05
mRNA FK866 GDSC1000 pan-cancer AAC -0.13 2e-05
Download CSV